Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Friday, July 31, 2026.
Reported quarterly profit margin; no daily interpolation. Q3 FY2026 (2026-07-31): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
-73.57%
NET PROFIT MARGIN AVG 20Y
-320.05%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
+100.00%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 451 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Anixa Biosciences, Inc.
Market Cap
$100.37M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$104.07M
Net Profit Margin
-72.28%
TTM Avg
-110.67%
3Y Avg
-76.27%
5Y Avg
-63.46%
Market Cap
$106.23M
Net Profit Margin
-33.92%
TTM Avg
-11.74%
3Y Avg
-13.15%
5Y Avg
-11.88%
Market Cap
$93.99M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$108.39M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-1332.08%
Market Cap
$91.68M
Net Profit Margin
0.00%
TTM Avg
-9.81%
3Y Avg
-113.18%
5Y Avg
-75.45%
Market Cap
$91.33M
Net Profit Margin
-39.96%
TTM Avg
-45.40%
3Y Avg
-116.56%
5Y Avg
-242.44%
Market Cap
$109.49M
Net Profit Margin
-14.78%
TTM Avg
-35.00%
3Y Avg
-39.46%
5Y Avg
-38.67%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Anixa Biosciences, Inc. (ANIX) | $100.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| Definitive Healthcare Corp. (DH)vs › | $104.07M | -72.28% | -110.67% | -76.27% | -63.46% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.23M | -33.92% | -11.74% | -13.15% | -11.88% |
| Biomea Fusion, Inc. (BMEA)vs › | $93.99M | 0.00% | 0.00% | 0.00% | 0.00% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.39M | 0.00% | 0.00% | 0.00% | -1332.08% |
| Equillium, Inc. (EQ)vs › | $91.68M | 0.00% | -9.81% | -113.18% | -75.45% |
| electroCore, Inc. (ECOR)vs › | $91.33M | -39.96% | -45.40% | -116.56% | -242.44% |
| Apyx Medical Corporation (APYX)vs › | $109.49M | -14.78% | -35.00% | -39.46% | -38.67% |
| Immunic, Inc. (IMUX)vs › | $109.93M | 0.00% | 0.00% | 0.00% | 0.00% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $111.17M | 31.95% | 15.97% | 7.99% | 5.33% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-07-31 | 0.00% |
| 2026-04-30 | 0.00% |
| 2026-01-31 | 0.00% |
| 2025-10-31 | 0.00% |
| 2025-07-31 | 0.00% |
| 2025-04-30 | 0.00% |
| 2025-01-31 | 0.00% |
| 2024-10-31 | 0.00% |
| 2024-07-31 | 0.00% |
| 2024-04-30 | 0.00% |
| 2024-01-31 | 0.00% |
| 2023-10-31 | 0.00% |
| 2023-07-31 | 0.00% |
| 2023-04-30 | -1089.52% |
| 2023-01-31 | 0.00% |
| 2022-10-31 | 0.00% |
| 2022-07-31 | 0.00% |
| 2022-04-30 | 0.00% |
| 2022-01-31 | 0.00% |
| 2021-10-31 | 0.00% |
| 2021-07-31 | 0.00% |
| 2021-04-30 | 0.00% |
| 2021-01-31 | -430.47% |
| 2020-10-31 | 0.00% |
| 2020-07-31 | 0.00% |
| 2020-04-30 | 0.00% |
| 2020-01-31 | 0.00% |
| 2019-10-31 | 0.00% |
| 2019-07-31 | 0.00% |
| 2019-04-30 | -1015.08% |
| 2019-01-31 | 0.00% |
| 2018-10-31 | 0.00% |
| 2018-07-31 | -1510.88% |
| 2018-04-30 | -183.80% |
| 2018-01-31 | 0.00% |
| 2017-10-31 | 0.00% |
| 2017-07-31 | -495.01% |
| 2017-04-30 | 0.00% |
| 2017-01-31 | 0.00% |
| 2016-10-31 | -523.83% |
| 2016-07-31 | -1103.78% |
| 2016-04-30 | 0.00% |
| 2016-01-31 | 0.00% |
| 2015-10-31 | 0.00% |
| 2015-07-31 | -1686.50% |
| 2015-04-30 | -8946.68% |
| 2015-01-31 | 41.08% |
| 2014-10-31 | -229.34% |
| 2014-07-31 | 34.62% |
| 2014-04-30 | -294.07% |
| 2014-01-31 | 0.00% |
| 2013-10-31 | -756.81% |
| 2013-07-31 | 0.00% |
| 2013-04-30 | 0.00% |
| 2013-01-31 | 0.00% |
| 2012-10-31 | -531572.29% |
| 2012-07-31 | -252.18% |
| 2012-04-30 | -353.57% |
| 2012-01-31 | -197.26% |
| 2011-10-31 | -621.75% |
| 2011-07-31 | -393.80% |
| 2011-04-30 | -1480.80% |
| 2011-01-31 | -8999.35% |
| 2010-10-31 | -362.07% |
| 2010-07-31 | -2188.75% |
| 2010-04-30 | -394.36% |
| 2010-01-31 | -3874.88% |
| 2009-10-31 | -10560.92% |
| 2009-07-31 | -395.56% |
| 2009-04-30 | -511.57% |
| 2009-01-31 | -367.45% |
| 2008-10-31 | -58.72% |
| 2008-07-31 | -82.66% |
| 2008-04-30 | -1113.57% |
| 2008-01-31 | -5141.84% |
| 2007-10-31 | -821.94% |
| 2007-07-31 | -925.90% |
| 2007-04-30 | -1484.95% |
| 2007-01-31 | -1356.35% |
| 2006-10-31 | -1624.48% |
| 2006-07-31 | -1641.08% |
| 2006-04-30 | -3372.86% |
| 2006-01-31 | -634.40% |
| 2005-10-31 | -2369.14% |
| 2005-07-31 | -846.97% |
| 2005-04-30 | -2526.27% |
| 2005-01-31 | -473.44% |
| 2004-10-31 | -599.22% |
| 2004-07-31 | -477.81% |
| 2004-04-30 | -682.59% |
| 2004-01-31 | -2075.27% |
| 2003-10-31 | -1438.50% |
| 2003-07-31 | -781.79% |
| 2003-04-30 | -4461.32% |
| 2003-01-31 | -880.89% |
| 2002-10-31 | -3139.02% |
